Drugmakers Pump Billions into New Gene Therapy Production Facilities

In a move to control some of the world’s most expensive medicine, nearly a dozen drugmakers have allocated in aggregated $2 billion to invest in the manufacturing of gene therapy. Drugmakers Pfizer and Novartis are leading the pack...

RELATED ARTICLESMORE FROM AUTHOR